These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2946223

  • 1. General overview and update of positive inotropic therapy.
    Leier CV.
    Am J Med; 1986 Oct 31; 81(4C):40-5. PubMed ID: 2946223
    [Abstract] [Full Text] [Related]

  • 2. Use of inotropes in the critical care setting.
    Löllgen H, Drexler H.
    Crit Care Med; 1990 Jan 31; 18(1 Pt 2):S56-60. PubMed ID: 2136722
    [Abstract] [Full Text] [Related]

  • 3. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E, De Coster P, Gonzalez M, Brichant C, Lessire H, Cauwe F.
    Eur Heart J; 1991 Sep 31; 12(9):985-93. PubMed ID: 1834466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F, Peters P, Schneider M.
    Z Kardiol; 1991 Sep 31; 80 Suppl 4():63-7. PubMed ID: 1833900
    [Abstract] [Full Text] [Related]

  • 6. Some new positive inotropic agents.
    Andersson KE.
    Acta Med Scand Suppl; 1986 Sep 31; 707():65-73. PubMed ID: 2874692
    [Abstract] [Full Text] [Related]

  • 7. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH, Keren G, Reis D, Sonnenblick EH.
    J Cardiovasc Pharmacol; 1986 Sep 31; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [Abstract] [Full Text] [Related]

  • 8. The new inotropic phosphodiesterase inhibitors.
    el Allaf D, D'Orio V, Carlier J.
    Arch Int Physiol Biochim; 1984 Nov 31; 92(4):S69-79. PubMed ID: 6085243
    [Abstract] [Full Text] [Related]

  • 9. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    Colucci WS, Wright RF, Braunwald E.
    N Engl J Med; 1986 Feb 06; 314(6):349-58. PubMed ID: 2418353
    [No Abstract] [Full Text] [Related]

  • 10. New positive inotropic drugs in the treatment of congestive heart failure.
    Kennedy GT.
    Prog Cardiovasc Nurs; 1987 Feb 06; 2(3):100-4. PubMed ID: 2959954
    [No Abstract] [Full Text] [Related]

  • 11. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R, De Marino V, Marino A.
    Clin Ter; 1991 Jan 31; 136(2):85-94. PubMed ID: 1827377
    [Abstract] [Full Text] [Related]

  • 12. [New positive inotropic drugs].
    Lehot JJ.
    Ann Fr Anesth Reanim; 1991 Jan 31; 10(1):62-9. PubMed ID: 1672585
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery.
    Rathmell JP, Prielipp RC, Butterworth JF, Williams E, Villamaria F, Testa L, Viscomi C, Ittleman FP, Baisden CE, Royster RL.
    Anesth Analg; 1998 Apr 31; 86(4):683-90. PubMed ID: 9539583
    [Abstract] [Full Text] [Related]

  • 16. Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
    Tommaso CL.
    Am J Med; 1986 Feb 28; 80(2B):36-9. PubMed ID: 3004210
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of inotropic support of the failing heart.
    Knight DH.
    Vet Clin North Am Small Anim Pract; 1991 Sep 28; 21(5):879-904. PubMed ID: 1949498
    [Abstract] [Full Text] [Related]

  • 18. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C, Rochoux G, Coste P, Le Goff G, Besse P.
    Arch Mal Coeur Vaiss; 1990 Sep 28; 83 Spec No 3():43-50. PubMed ID: 2147834
    [Abstract] [Full Text] [Related]

  • 19. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT, Janicki JS, Jain MC.
    J Heart Transplant; 1986 Sep 28; 5(2):105-12. PubMed ID: 2956397
    [Abstract] [Full Text] [Related]

  • 20. [New positive inotropic drugs in acute and chronic heart failure].
    Follath F.
    Schweiz Rundsch Med Prax; 1992 May 19; 81(21):704-7. PubMed ID: 1351309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.